Showing results (71-80 of 87) with videos related to
Sort By:
Pageof 9
Nature|December 14, 2012
CCR5 is a receptor for Staphylococcus aureus leukotoxin EDFrancis Alonzo, Lina Kozhaya, Stephen A Rawlings, et al.Mbio|June 1, 2021
Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant SpikesTakuya Tada, Belinda M Dcosta, Marie I Samanovic, et al.Journal of Molecular Biology|December 14, 2020
The ACE2-binding Interface of SARS-CoV-2 Spike Inherently Deflects Immune RecognitionTakamitsu Hattori, Akiko Koide, Maria G Noval, et al.Cell Reports|December 16, 2020
An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2Takuya Tada, Chen Fan, Jennifer S Chen, et al.Antimicrobial Agents and Chemotherapy|May 29, 2014
SAMHD1 has differential impact on the efficacies of HIV nucleoside reverse transcriptase inhibitorsAndrew D Huber, Eleftherios Michailidis, Megan L Schultz, et al.Nature Immunology|February 14, 2012
SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphatesHichem Lahouassa, Waaqo Daddacha, Henning Hofmann, et al.Cell Death and Differentiation|December 4, 2021
The NSP14/NSP10 RNA repair complex as a Pan-coronavirus therapeutic targetGergely Rona, Andras Zeke, Bearach Miwatani-Minter, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|November 22, 2023
Removal of innate immune barriers allows efficient transduction of quiescent human hematopoietic stem cellsErika Valeri, Giulia Unali, Francesco Piras, et al.Nature Medicine|September 14, 2012
SAMHD1 restricts HIV-1 infection in resting CD4(+) T cellsHanna-Mari Baldauf, Xiaoyu Pan, Elina Erikson, et al.Biorxiv : the Preprint Server for Biology|April 12, 2022
Delta-Omicron recombinant escapes therapeutic antibody neutralizationRalf Duerr, Hao Zhou, Takuya Tada, et al.Pageof 9